Lidocaine and Epinephrine Bitartrate
LIDOCAINE, Xylocaine
NADAC/unit
N/A
No Shortage
Market Intelligence
2025-12-24 Class II Recall: Novocol Pharmaceutical of Canada, Inc.
2025-12-24 Class II Recall: Novocol Pharmaceutical of Canada, Inc.
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
